Browse Category

Investment News 3 November 2025 - 4 November 2025

TG Therapeutics Stock Soars on Briumvi Boom – Key Facts, Analyst Insights & 2025 Outlook

TG Therapeutics Stock Soars on Briumvi Boom – Key Facts, Analyst Insights & 2025 Outlook

Company Overview: Briumvi-Focused Business Model TG Therapeutics, Inc. is a commercial-stage biopharmaceutical company specializing in treatments for B-cell mediated diseases gurufocus.com. After years as a development-stage biotech, TG entered the commercial arena with Briumvi, its first approved product, and now
3 November 2025
DroneShield Stock Skyrockets 40%: What’s Behind the Surge and What’s Next?

DroneShield’s Wild Ride: 400% Defense-Tech Surge, October Crash, and a $25 Million Deal – What’s Next?

From 10× Surge to 30% Plunge: DroneShield’s Rollercoaster Few stocks illustrate 2025’s defense-tech frenzy better than DroneShield. The Sydney-based counter-drone specialist entered the year as a little-known penny stock (around A$0.60), then rode a wave of war-driven demand to an
1 30 31 32 33 34 55
Go toTop